Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LXEO is expected to report earnings to fall 8.08% to -91 cents per share on August 18
Q2'25
Est.
$-0.91
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.13
The last earnings report on May 13 showed earnings per share of -99 cents, missing the estimate of -88 cents. With 1.93M shares outstanding, the current market capitalization sits at 128.78M.